ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is NovaBay Pharmaceuticals, Inc. ?
Unrated Stock - No Analysis Available
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-12.38%
EBIT Growth (5y)
-1.22%
EBIT to Interest (avg)
-6.70
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.32
Sales to Capital Employed (avg)
4.81
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.85%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.55
EV to EBIT
0.78
EV to EBITDA
0.80
EV to Capital Employed
2.43
EV to Sales
-0.66
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
313.51%
ROE (Latest)
-109.52%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET PROFIT(HY)
Higher at USD -4.71 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 3 times
DEBTORS TURNOVER RATIO(HY)
Highest at 17.27 times
-10What is not working for the Company
NET SALES(9M)
At USD 2.31 MM has Grown at -73.64%
INTEREST(9M)
At USD 0.09 MM has Grown at inf%
OPERATING CASH FLOW(Y)
Lowest at USD -7.23 MM
Here's what is working for NovaBay Pharmaceuticals, Inc.
Net Profit
Higher at USD -4.71 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Inventory Turnover Ratio
Highest at 3 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 17.27 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for NovaBay Pharmaceuticals, Inc.
Net Sales
At USD 2.31 MM has Grown at -73.64%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Interest
At USD 0.09 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Cash Flow
Lowest at USD -7.23 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
